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ATF2MicroRNAs (miRNAs) are small, non-coding RNAs that regulate gene expression at the post-transcriptional
level. Emerging evidence suggests that differential miRNA expression is associated with viral infection and
cancer. Marek's disease virus infection induces lymphoma in chickens. However, the host defense response
against Marek's disease (MD) progression remains poorly understood. Here, we utilized microarrays to
screen miRNAs that were sensitive to Marek's disease virus (MDV) infection. QRT-PCR analysis conﬁrmed
the microarray data and revealed expression patterns of some miRNAs in tumor samples. Chicken miRNA
gga-miR-15b, which was reduced in infected susceptible chickens and splenic tumors, controlled the expres-
sion of ATF2 (activating transcription factor 2). ATF2 was signiﬁcantly increased in the same group. Our
results indicated that differential expression of miRNA in resistant and susceptible chickens was caused by
MDV infection, which effectively inﬂuenced protein expression of ATF2. This latter result might be related
to Marek's disease resistance/susceptibility.
© 2011 Elsevier Inc. All rights reserved.1. Introduction
MicroRNAs (miRNAs) are a class of small single-stranded, non-
coding RNAs (~22 nt in length) that govern post-transcriptional repres-
sion of target genes by binding to 3′ untranslated regions (3′ UTRs) or
gene bodies [13]. It has been shown that miRNAs are involved in a
broad range of biological processes, including development, metabo-
lism and cell differentiation [11,13]. MiRNAs have been speciﬁcally im-
plicated in tumorigenesis and pathogen infection [11,19]. Functional
evaluations of differentially expressed miRNAs have uncovered their
abilities to elicit diverse immune responses, mainly through the regula-
tion of immune cell differentiation and their associationwith immunity
and inﬂammation [2,19,22].
Marek's disease (MD) is chicken lymphoma caused by Marek's
disease virus 1 (MDV1), which is an α-herpesvirus that is closely re-
lated to human herpesvirus 1 (herpes simplex virus type 1, HSV-1)
and human herpesvirus 3 (varicella-zoster virus, VZV) [24]. MDV in-
fection exhibits an early cytolytic phase between 3 and 7 days post in-
fection (dpi) and then enters into the latent phase within 2 weeks.
During this period, the MDV genome is maintained in host cells with-
out the production of infectious progeny viruses [24]. Reactivation of
MDV to the late cytolytic phase occurs between 14 and 21 dpi in MD
susceptible chickens, which coincides with permanent immunosup-
pression [8,24]. Here, we analyzed miRNA expression proﬁles inrights reserved.MD-resistant and MD-susceptible chickens to elucidate the function
of miRNA in the regulation of Marek's disease (MD) resistance.
To date, 499 predicted and conﬁrmed chicken miRNAs as well as
14 MDV-1 miRNAs have been released from miRBase (http://
miRNA.sanger.ac.uk/sequences/). A portion of chicken miRNAs was
repressed in MDV-infected chicken embryo ﬁbroblast cells [7] and
displayed dynamic expression patterns during the development of
chicken immune organs [14]. Several MDV-1 miRNAs, including
MDV1-M2, MDV1-M3 and MDV1-M5 have been physically mapped
to the regions ﬂanking the MDV oncogeneMeq [6]. However, the dif-
ferences in miRNA expression between MD-resistant and MD-
susceptible chickens, especially before and after MDV infection, are
still unknown. These variations appear to be important for under-
standing host–virus interactions. In this study, we used two highly in-
bred chicken lines (line 63 and line 72) to evaluate the hypothesis that
MDV infection induces distinct miRNA expression signatures in MD-
resistant and MD-susceptible chickens that modulate target gene ex-
pression. MDV can enter target cells in line 63 and line 72 chickens,
but line 63 chickens survive after infection and most of them do not
develop tumors. In contrast, line 72 is susceptible to MD, which
leads to the development of lymphoma. Using this model, we identi-
ﬁed 64 candidate miRNAs that were differentially expressed in the
spleens of MDV-infected and noninfected line 72 chickens. Among
these miRNAs, gga-miR-15b deregulation in infected line 72 was
shown to control the expression of activating transcription factor 2
(ATF2), which was increased in infected line 72 chickens. Collectively,
our data demonstrated that MDV infection caused distinct miRNA ex-
pression patterns in MD resistant andMD susceptible chickens, which
effectively inﬂuence the protein levels of target gene in the infected
Table 1
Real time-PCR.
Genea Sequencesb
ATF2c Forward 5′-CCTCCCCACAGCCAGTGCAG-3′
Reverse 5′-TGAGCTGGTGATGCCGGTGT-3′
Meqc Forward 5′-AAGTCACGACATCCCCAACAGC-3′
Reverse 5′-TACATAGTCCGTCTGCTTCCTGCG-3′
GAPDHc Forward 5′-GAGGGTAGTGAAGGCTGCTG-3′
Reverse 5′-ACCAGGAAACAAGCTTGACG-3′
Vimc Forward 5′-CAGCCACAGAGTAGGGTAGTC-3′
Reverse 5′-GAATAGGGAAGAACAGGAAAT-3′
ATF2d Forward 5′-GTTTAAAC TCCAGGCCCGTTTCCTCTGCT-3′
Reverse 5′-TCTAGA AGCTTCCGTGTGTGGGCTGC-3′
a Gene name.
b Y and R stand for C/T and G/A, respectively.
c Primers for real time-PCR.
d Primers for amplifying ATF2 fragments that contain microRNA interacting sites and
for plasmid construction.
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ration of how miRNAs are regulated in viral-induced tumors in vivo.
2. Materials and methods
2.1. Experimental animals and sample preparation
Line 63 and line 72 (USDA-ARS Avian Disease and Oncology Labo-
ratory, East Lansing, Michigan, USA) are two highly inbred lines of
speciﬁc-pathogen-free white leghorn chickens that are resistant and
susceptible, respectively, to MD tumors. Chickens from each line
were separated into two groups. One group was infected with a
very virulent (vv+) strain of MDV (648A passage 40) at day 5 after
hatching, while the other group did not receive MDV. Four chickens
were selected from each group at 5, 10 and 21 days post infection
(dpi), and none of them developed tumors during the experiment
period. Besides the infected spleen samples from line 63 and line 72,
we received 4 spleen tumor samples of MDV infected chickens and
4 spleen samples of uninfected control birds from Avian Disease and
Oncology Laboratory (ADOL, USDA). The tumor diagnosis and tumor
sample collection were done by the veterinary medical ofﬁcer in
ADOL. Fresh spleen samples were harvested individually and stored
in RNAlater solution (QIAGEN) at−80 °C for DNA or RNA extraction.
The entire animal experiment was conducted following the proce-
dures and guidelines described in the “Guidelines for Animal Care
and Use” manual approved by the Animal Care and Use Committee,
the USDA-ARS, and the Avian Disease and Oncology Laboratory
(Approval ID 111–26).
2.2. Quantiﬁcation of MDV genome DNA loads in spleen samples
As previously described [1], the MDV oncogene Meq was used to
quantify viral genomic DNA at 5, 10 and 21 dpi. Quantitative PCR of
the viral copy number was performed on genomic DNA (100 ng/μl)
with the iCycler iQ PCR system (Bio-Rad, USA) and QuantiTect SYBR
Green PCR Kit (Qiagen, USA). Relative MDV loads were determined
after normalization to a single-copy gene VIM (vimentin) [33].
2.3. MiRNA array proﬁling and data analysis
Total RNAwas extracted from three spleen samples using the miR-
Neasy Mini Kit (QIAGEN). Total RNA quality was veriﬁed with Agilent
2100 Bioanalyzer chips (Agilent, Santa Clara, CA, USA). Three of the
samples from each of the treatment groups from two chicken lines
were processed for miRNA microarray analysis. Total RNA (1 μg)
from each of the samples and the common reference sample were la-
beled with Hy3™ and Hy5™ ﬂuorescent label, respectively, using the
miRCURY™ LNA Array power labeling kit (Exiqon, Denmark) follow-
ing the manufacturer's speciﬁcations. The Hy3™-labeled samples
and a Hy5™-labeled reference RNA sample were mixed pair-wise
and hybridized to the miRCURY™ LNA array (Version 9.2; Exiqon,
Denmark), which contained capture probes targeting all of the miR-
NAs for all the species registered in the miRBASE (Version 10.1) at
the Sanger Institute. One hundred and sixty-two of these probes
were chicken-related miRNAs. Hybridization was performed accord-
ing to the miRCURY™ LNA array manual with a Tecan HS4800 hybrid-
ization station (Tecan, Austria). After hybridization, the microarray
slides were scanned and stored in an ozone free environment
(ozone level below 2.0 ppb) to prevent potential bleaching of the
ﬂuorescent dyes. The miRCURY™ LNA array microarray slides were
scanned using the Agilent G2565BA Microarray Scanner System
(Agilent Technologies, Inc., USA) and image analysis was performed
with ImaGene 8.0 software (BioDiscovery, Inc., USA). Microarray
data were analyzed in R using the Limma package [29,30]. Quantiﬁed
signals within arrays were averaged and normalized using the
global LOWESS (LOcally WEighted Scatterplot Smoothing) regressionalgorithm. Contrasts were made to compare noninfected and infected
groups in both lines. Differentially expressed miRNAs were selected
to perform cluster analysis with CLUSTER/TreeView software [10].
The target genes for miRNAs were predicted by RNA22 (http://
cbcsrv.watson.ibm.com/rna22.html).
2.4. Quantiﬁcation of miRNA and mRNA levels using real-time PCR
MiRNAs and mRNAs were extracted from four chicken spleen
samples per treatment group using the miRNeasy Mini Kit (QIAGEN)
and RNeasy Mini Kit (QIAGEN) according to the standard protocol by
manufacturer including the on-column DNase digestion, respectively.
MiRNA samples were reverse transcribed and quantiﬁed with a miS-
cript Reverse Transcription Kit (QIAGEN), a miScript SYBR Green PCR
Kit (QIAGEN), and 11 miScript Primer assays (QIAGEN). Reverse tran-
scription and quantiﬁcation of mRNA were performed with Super-
Script™ III Reverse Transcriptase (Invitrogen) with oligo (dT)12–18
primers (Invitrogen), and the QuantiTect SYBR Green PCR Kit. In the
reverse transcription control, PCR water (Invitrogen) was used to re-
place miRNA or RNA samples. Brieﬂy, 1 μg of puriﬁed miRNA or total
RNA was used for reverse transcription, respectively, and 2 μl of RT
products (1:5 dilution) were used for real-time PCR quantiﬁcation.
Two types of controls were applied in real-time PCR, including re-
verse transcription control and blank using PCR water. No amplicon
was observed in the controls. The forward and reverse primers for
ATF2 and Meq quantiﬁcation are listed in Table 1. A ﬁnal volume of
20 μl real-time PCR product was incubated in an iCycler iQ PCR Sys-
tem (Bio-Rad), and each was performed on four biological replicates
from the treatment per line in each experiment. Three independent
experiments were carried out for each gene and miRNA. U6 or
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was used as
normalization control for the data [32]. After normalization, ANOVA
and Tukey test were used to compare the miRNAs or genes expres-
sion levels (SAS version 9.2).
2.5. Western blot
Total protein was extracted by lysis of ~20 mg of tissues with RIPA
buffer (150 mM sodium chloride, 1.0% NP-40, 0.5% sodium deoxycho-
late, 0.1% SDS and 50 mM Tris, pH 8.0) containing a protease inhibitor
cocktail (Sigma). Approximately 20 mg of splenic tissue was homog-
enized in RIPA buffer, and the lysate was incubated at 4 °C for 2 h
with constant agitation and subsequently centrifuged at 4 °C for
30 min. Protein concentration for each sample was determined by
the BCA assay (Thermo Scientiﬁc). For the Western blotting, 30 μg
of extracted protein was heated at 95–100 °C for 5 min and loaded
on 10% SDS-PAGE for electrophoresis. After separation, proteins
were transferred onto polyvinylidene ﬂuoride (PVDF) membrane
Table 2b
Differentially expressed chicken microRNAs between infected and noninfected line 72
groups.
Name logFC p Value FDR
gga-miR-99a 1.760595 3.29E−06 5.92E−05
gga-miR-181a 1.949209 4.76E−06 6.91E−05
gga-miR-181b 1.741941 5.12E−06 6.91E−05
gga-miR-103 1.350569 1.18E−05 0.000148
gga-miR-128 1.263305 1.93E−05 0.000223
gga-miR-455 1.273726 5.08E−05 0.000549
gga-let-7b 1.241415 5.84E−05 0.000591
gga-miR-10b 1.214064 0.000101 0.000915
gga-miR-456 1.166798 0.000113 0.000915
gga-miR-1b 1.208345 0.000166 0.00128
gga-miR-107 1.260672 0.000174 0.001283
gga-miR-30a-3p 1.744581 0.000225 0.001587
gga-miR-100 1.145376 0.000312 0.002104
gga-let-7a/gga-let-7j 1.325531 0.00036 0.002308
gga-miR-146a −1.21913 0.00037 0.002308
gga-miR-30d 1.087841 0.0004 0.0024
gga-miR-147 −1.01843 0.000542 0.003135
gga-miR-17-3p 1.220382 0.000676 0.003776
gga-miR-218 1.116341 0.000703 0.003795
gga-miR-9 1.110438 0.000789 0.004124
gga-miR-138 0.809944 0.001534 0.00751
gga-let-7f 0.795792 0.001566 0.00751
gga-miR-199 0.762491 0.001576 0.00751
gga-miR-124a 0.923271 0.001945 0.009004
gga-miR-18b 0.836313 0.002905 0.01286
gga-miR-125b 0.870999 0.002937 0.01286
gga-miR-153 1.453438 0.003084 0.013146
gga-miR-221 0.782907 0.003887 0.016148
gga-miR-30c 0.703324 0.004367 0.017688
gga-miR-92 0.864246 0.004583 0.018108
gga-miR-133b 0.920419 0.00512 0.019748
gga-miR-204/gga-miR-211 0.860571 0.006747 0.025417
gga-miR-30a-5p 0.708035 0.007139 0.026286
gga-let-7c 0.74543 0.007522 0.027077
gga-miR-30b 0.576117 0.008145 0.027771
gga-miR-199* 0.97806 0.008242 0.027771
gga-miR-302b* −0.78133 0.008365 0.027771
gga-miR-181a* 0.908167 0.0092 0.029596
gga-let-7k 1.067455 0.009317 0.029596
gga-miR-140 0.616854 0.009505 0.029611
gga-miR-193 0.772655 0.010378 0.031715
gga-miR-27b 0.814612 0.011326 0.033361
gga-miR-148a 0.927259 0.011542 0.03339
gga-miR-126 0.979227 0.012862 0.036554
gga-let-7i 0.54566 0.013985 0.039062
gga-miR-33 0.785207 0.014266 0.039171
gga-miR-466 −1.39321 0.014926 0.040066
gga-miR-126* 0.818411 0.015086 0.040066
gga-miR-34a 0.508048 0.015553 0.040638
gga-miR-18a 0.766642 0.015945 0.041002
gga-miR-15b 0.530495 0.016677 0.041865
gga-miR-375 0.66711 0.016798 0.041865
gga-miR-223 −0.69745 0.018769 0.04551
gga-let-7g 0.576923 0.018822 0.04551
gga-miR-190 0.667463 0.021096 0.050258
gga-miR-7 −0.59965 0.0216 0.050714
gga-miR-184 −0.79159 0.025407 0.058799
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Primary antibodies (Santa Cruz) against ATF2 and β-actin were pre-
pared at 1:500 and 1:1000 dilutions in TBST, respectively. Membranes
were incubated with primary antibodies overnight at 4 °C. Mem-
branes were washed quickly 3 times (less than 1 min) and 3 more
times for 5 min. Membranes were then incubated with anti-rabbit
IgG and anti-mouse IgG secondary antibodies (Santa Cruz) diluted
in TBST (1:5000) for 1 h at room temperature. The membranes
were quickly washed 3 times and then washed 3 more times for
5 min each. Membranes were developed with ECL (Amersham) and
measured using ChemiDoc XRS (Bio-Rad). Four independent experi-
ments were done for each antibody.
2.6. Cell culture, plasmid constructs, transfection and luciferase reporter
assay
Hela cells were grown in Dulbecco's modiﬁed Eagle's medium
supplemented with 10%, fetal bovine serum, streptomycin (100 mg/
ml) and penicillin (100 U/ml) (Invitrogen). Cells were maintained at
37 °C in humidiﬁed 5% CO2 conditions. ATF2 cDNA fragments contain-
ing miRNA target sequences were ampliﬁed by PCR (primers in Table
S1), and cloned into pmirGLO Dual-Luciferase miRNA target expres-
sion vector (Promega) to create plasmid constructs. For transfection,
cells were plated in 24-well plates and were ~25% conﬂuent 24 h be-
fore transfection. Before transfection, the medium was replaced
with growth medium without antibiotics. Chicken miRNA mimics
(QIAGEN) were diluted to working concentration(3 pmol/μl), and
were co-transfected with plasmids (500 ng) harboring miRNA target
sites using Lipofectamine 2000 transfection reagent (Invitrogen),
and the medium was replaced with normal growth medium 4–6 h
later. Cells were harvested after 24 h, and Renilla and ﬁreﬂy luciferase
activities were measured using Dual-Luciferase Reporter Assay Sys-
tem (Promega).
3. Results
3.1. MiRNA expression proﬁles
Based on our criterion (p-value less than 0.05 and false discovery
rate (FDR) smaller than 0.1), 64 out of the 162 miRNAs had signiﬁcant
differential expression between infected and noninfected line 72
chickens at 21 dpi, including the downregulation of 58 miRNAs and
the upregulation of 6 miRNAs in the infected line 72 group
(Tables 2a, 2b). Notably, using the same criteria, none of the miRNAs
were expressed differently between the infected and noninfected line
63 chickens (Table 2a). Sixty-two miRNAs were expressed differently
when infected line 63 and line 72 chickens were compared, including
50 downregulated and 12 upregulated miRNAs in the infected line 72
group (Tables 2a, 2c). In total, 73 miRNAs showed differential expres-
sion. By using the cluster analysis that included all of the signiﬁcantly
expressed miRNAs, we found that the experimental birds wereTable 2a
Numbers of chicken microRNAs differentially expressed between chicken lines and
MDV treatment groups.
L63.non vs.
L63.inf
L72.non vs.
L72.inf
L63.non vs.
L72.non
L63.inf vs.
L72.inf
Downregulated 0 58a 0 50c
Upregulated 0 6b 0 12d
Total 0 64 0 62
a and c: MicroRNA levels were downregulated in the infected line 72 chickens
compared to noninfected line 72 or infected line 63 chickens, respectively, based on
pb0.05 and FDRb0.1.
b and d: MicroRNA levels were upregulated in the infected line 72 chickens compared to
noninfected line 72 or infected line 63 chickens, respectively, based on pb0.05 and
FDRb0. 1.
gga-miR-499 0.604568 0.025957 0.059226
gga-miR-17-5p 0.643931 0.032926 0.073068
gga-miR-21 −0.70144 0.033677 0.073726
gga-miR-122 0.701345 0.039442 0.084073
gga-miR-205b −0.53455 0.040507 0.085223
gga-miR-26a 0.658442 0.04147 0.086131
gga-miR-489 0.750998 0.046173 0.094684
log FC was computed as log2 noninfectedline72

infectedline72
 
.categorized into two groups (Fig. 1). The infected line 72 birds were
in one subgroup. In the other subgroup, noninfected line 72 chickens
were associated with the line 63 chickens that were both infected and
noninfected, indicating that their microRNA proﬁles were less varied
(Fig. 2). Additionally, we also found that the abundance of 10 MDV1
Table 2c
Differentially expressed chicken microRNAs between infected line 63 and line 72
groups.
Name logFC p Value FDR
gga-miR-99a 2.22393 2.71E−07 8.79E−06
gga-miR-455 1.594012 5.64E−06 9.14E−05
gga-miR-100 1.69626 8.07E−06 0.000119
gga-miR-10b 1.431896 2.15E−05 0.00029
gga-let-7b 1.293156 3.98E−05 0.000461
gga-miR-181a 1.49834 6.25E−05 0.000622
gga-miR-125b 1.390395 6.70E−05 0.000622
gga-miR-181b 1.334056 6.91E−05 0.000622
gga-miR-147 −1.26644 8.28E−05 0.000697
gga-miR-199 1.084724 8.60E−05 0.000697
gga-miR-103 1.088025 9.30E−05 0.000717
gga-miR-107 1.329872 0.000108 0.000799
gga-let-7c 1.150765 0.000329 0.00232
gga-miR-153 1.847916 0.000515 0.003361
gga-miR-146a −1.17015 0.000519 0.003361
gga-miR-128 0.868683 0.000553 0.003445
gga-miR-126* 1.319732 0.000635 0.003808
gga-miR-218 1.123449 0.000668 0.003867
gga-let-7f 0.884625 0.0007 0.003908
gga-miR-302b* −1.10584 0.000771 0.004163
gga-miR-30a-3p 1.437773 0.001082 0.005538
gga-miR-199* 1.306179 0.001181 0.0058
gga-miR-1b 0.921415 0.001487 0.006902
gga-miR-456 0.851689 0.001491 0.006902
gga-miR-34a 0.734018 0.001538 0.006923
gga-miR-383 1.117926 0.001627 0.007124
gga-miR-30b 0.731435 0.001693 0.007216
gga-miR-30d 0.868993 0.002237 0.009293
gga-let-7k 1.303096 0.002632 0.010603
gga-miR-30c 0.756482 0.002683 0.010603
gga-let-7a/gga-let-7j 0.996138 0.003125 0.012054
gga-miR-193 0.913973 0.003701 0.013626
gga-miR-148a 1.092814 0.004294 0.015457
gga-miR-205b −0.81643 0.004549 0.01568
gga-miR-122 1.046192 0.004798 0.015976
gga-miR-7 −0.78138 0.004874 0.015976
gga-miR-365 0.653083 0.008264 0.025158
gga-miR-200b 1.649155 0.008472 0.025158
gga-miR-200a 1.683736 0.008649 0.025158
gga-miR-26a 0.901929 0.008696 0.025158
gga-miR-27b 0.835299 0.009832 0.027944
gga-miR-184 −0.92207 0.011634 0.032494
gga-miR-126 0.988679 0.012204 0.033508
gga-miR-190 0.71046 0.01536 0.041472
gga-miR-124a 0.657104 0.015924 0.04229
gga-miR-142-5p −0.8538 0.017161 0.044128
gga-miR-466 −1.33813 0.018389 0.046548
gga-miR-223 −0.69342 0.019322 0.048068
gga-let-7i 0.511276 0.019583 0.048068
gga-miR-138 0.528106 0.021019 0.050823
gga-miR-24 0.57525 0.02276 0.054222
gga-miR-429 1.645703 0.025175 0.059107
gga-miR-29b −0.6612 0.025809 0.059715
gga-miR-133b 0.683815 0.026171 0.059715
gga-miR-499 0.579396 0.031524 0.07093
gga-miR-21 −0.70396 0.033152 0.073569
gga-miR-18b 0.538932 0.033743 0.07387
gga-miR-221 0.524929 0.034307 0.074102
gga-miR-215 −0.7945 0.038339 0.079845
gga-let-7g 0.483645 0.042131 0.085316
gga-miR-140 0.448124 0.045048 0.090096
gga-miR-204/gga-miR-211 0.574843 0.049942 0.098665
logFC was computed as log2 infectedline63

infectedline72
 
.
Fig. 1. Hierarchical clustering analysis classiﬁed the samples based on signiﬁcantly dif-
ferentiated microRNA expression levels in the normalized data. Green or red bars
denote that the level of speciﬁc microRNA was decreased or increased in samples.
Black bars indicate that the levels of microRNA were similar between samples and
the common reference sample. Gray indicates data that are not available. The scale of
the color bar represents fold changes of microRNA expression relative to the common
reference. L72.inf.1–3: 3 samples from infected line 72; L72.non.inf.1–3: 3 samples from
noninfected lines 72; L63.non.inf.1–3: 3 samples from noninfected line 63; L63.inf.1–3: 3
samples from infected line 63.
155F. Tian et al. / Genomics 99 (2012) 152–159miRNAs dramatically increased in infected line 72 chickens but not in
infected line 63 birds (Table 2d).
Based on the results from the microarray analysis and the poten-
tial functions of selected miRNAs, 3 (gga-miR-15b, gga-miR-456 and
gga-let-7i miRNAs) were chosen to verify the results from the micro-
array analysis. The expressions of gga-miR-15b, gga-miR-456 and gga-
let-7iwere all signiﬁcantly downregulated in infected line 72 samplescompared to MDV-free chickens (pb0.05) (Fig. 2a). Signiﬁcantly re-
duced expressions of gga-miR-456 and gga-let-7i were observed in
infected line 72 chickens compared to infected line 63 chickens
(pb0.01 and pb0.05 respectively). Transcription of gga-miR-15b
was decreased in infected line 72 samples relative to infected line 63
samples, although this difference was not statistically signiﬁcant
(Fig. 2a). These 3 miRNAs did not show signiﬁcant variance between
infected and noninfected in line 63 samples. Additionally, these 3
miRNAs were also repressed in splenic MD tumors compared to
healthy spleen (pb0.05), which was consistent with the microarray
results (Fig. 2b). Besides chicken miRNAs, the expression levels of
MDV-miR-M2 and MDV-miR-M5 were signiﬁcantly higher in the
infected line 72 birds than in infected line 63 chickens (pb0.01)
(Fig. 3).
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To further understand the potential functions of miRNAs in MDV
resistance and susceptibility, we examined the protein and mRNA
levels of several genes that were reported to interact with MDV onco-
geneMeq. The protein level of activating transcription factor 2 (ATF2)
was signiﬁcantly increased in infected line 72 chickens compared
to MDV-free chickens, whereas its expression was stable in line 63
birds before and after MDV challenge (Fig. 4a). Comparably, qRT-
PCR revealed that the mRNA levels of ATF2 were slightly decreased
upon MDV infection in the two lines but were not signiﬁcantlyTable 2d
Differentially expressed MDV microRNAs in chickens of the infected line 63 and line 72
groups.
Name logFC p Value FDR
mdv1-miR-M6 −6.60394 1.65E−09 1.69E−07
mdv1-miR-M8 −7.54209 2.08E−09 1.69E−07
mdv1-miR-M5 −4.87375 2.78E−08 1.50E−06
mdv1-miR-M3 −5.11485 5.01E−08 1.58E−06
mdv1-miR-M2 −3.84215 5.60E−08 1.58E−06
mdv1-miR-M4 −6.64692 5.84E−08 1.58E−06
mdv1-miR-M2* −3.62937 5.76E−07 1.33E−05
mdv1-miR-M7 −3.55253 2.22E−06 4.50E−05
mdv1-miR-M1 −3.92847 4.08E−06 6.61E−05
mdv1-miR-M4* −2.50929 0.000102 0.000915
logFC was computed as log2 infectedline63

infectedline72
 
.different (Fig. 4b), indicating that miRNAs might be regulating ATF2
expression. By using a bioinformatic tool (RNAhybrid), 3 chicken
miRNAs (gga-miR-15b, gga-miR-456 and gga-let-7i) were found to
be among those differentially expressed and predicted to interact
with ATF2 mRNA in its coding regions (Fig. 4c). The speculation that
ATF2 translational regulation requires chicken miRNAs was veriﬁed
by the observation that induction of gga-miR-15b inhibited luciferase
activity by ~20% compared to negative control (pb0.05) (Fig. 4d).
However, the presence of gga-let-7i silenced ﬁreﬂy luciferase activity
by ~15% although this difference was not statistically signiﬁcant. We
also found that gga-miR-456 did not inﬂuence the translation activity
of the ATF2 (Fig. 4d).
4. Discussion
MDV successfully infected chickens from line 63 and line 72, but
this infection had discordant behavior in the two lines. By measuring
the copies of two important viral genes (Meq and ICP40), virus copy
number was estimated and was similar between infected line 63
and infected line 72 chickens at 5 dpi, but was much higher in infected
line 72 chickens than in infected line 63 chickens at 10 and 21 dpi (Fig.
S1). MDV has been reported to be relatively faster in line 72 than in
line 63 [16,26]. This phenomenon may be caused by the differential
expression of microRNAs or may lead to the distinct microRNA ex-
pression in these two lines; however, this requires further investiga-
tion. The highest virus copy number was found at 21 dpi in both lines,
and virus induced or repressed microRNAs could be detected at this
time point. Compared to high-throughput RNA sequencing, microar-
ray relies on the prior sequence information for probe designs, and fo-
cuses only on the well-studied miRNAs which were printed on the
array, therefore, inadequate to identify novel miRNAs. Despite these
limitations, array based approach is a feasible and cost-efﬁcient meth-
od, and is expected to identify differentially expressed miRNAs in
vivo. Therefore, to generate a global view of differentially expressed
microRNAs, microarray analysis was conducted on samples at 21 dpi.
The spleen is an important immune organ that provides a niche for
MDV to reach its primary targets (B cells and CD4+T cells) during in-
fection [24]. Because of the absence of classical transforming genes in
MDV, the environment provided by the spleen is critical for viral rep-
lication [5]. Moreover, previous researches have already documented
tissue-speciﬁc microRNA expression and methylation in different
species [5,18,23,31]. Therefore, all the experiments were carried out
using splenic samples. To gain insights into MDV-induced microRNA
expression variations in the immune system, this study proﬁled
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which will improve our knowledge of the MDV-chicken interaction.
Variation in miRNA expression induced by MDV infection has
been identiﬁed in chicken embryo ﬁbroblast (CEF), including some
miRNAs that also showed differential expression in our study [7].
Based on the current microarray cutoff for differential expression
(pb0.05 and FDRb0.1) in the microarray, miRNA expression was
only signiﬁcantly different between infected and noninfected line 72
groups, and between the infected line 63 and line 72 groups. This ﬁnd-
ing suggests that potential functions of these miRNAs were related to
MD resistance and susceptibility. However, we did observe signiﬁcant
miRNAs between line 63 infected and uninfected chickens or between
line 63 and line 72 with pb0.05, but none of these miRNAs were con-
ﬁrmed by qRT-PCR. Because microRNA expression signature follow-
ing MDV infection in line 63 and line 72 has not been studied, we
compared our results with cDNA microarray analysis in the two
lines. Previous studies examined gene expression in peripheral
blood lymphocytes (PBLs) in two chicken lines and revealed that
the expression of some genes showed at least two-fold changes be-
tween infected line 63 and line 72 chickens, while the transcriptional
proﬁles of uninfected birds were similar, which agreed with ourﬁndings [21]. Collectively, our results demonstrated that differential
expression of miRNAs was driven by MDV infection in line 63 and
line 72. Results from qRT-PCR were consistent with the microarray
analysis for both cellular and viral miRNAs. These data demonstrated
signiﬁcant inactivation of cellular miRNA production and the in-
creased MDV miRNA transcription in infected line 72 at 21 dpi.
Moreover, we found a set of miRNAs (gga-miR-15, gga-miR-456 and
gga-let-7i) that were deregulated in MD tumors, similar to infected
line 72, which implied their potential roles as tumor suppressors
and early indicators of MD progression. However, other miRNAs had
different transcriptional levels between tumor samples and infected
line 72 (data not shown), suggesting different functions in viral infec-
tion and tumorigenesis. In contrast to cellular miRNAs, all of the MDV
miRNAs were signiﬁcantly upregulated. For example, MDV1-miR-M2
and MDV1-miR-M5, located at the 5′ upstream of Meq [6], were over-
expressed in the infected line 72 at 21 dpi compared to the infected
line 63. This result is consistent with the higher DNA copy number
and activated transcription of Meq (Figs. S1 and S2), and highlighted
increased viral replication in infected line 72.
The candidate target genes regulated by differentially expressed
miRNAs were predicted using bioinformatic tools miRDB and MDV
158 F. Tian et al. / Genomics 99 (2012) 152–159MicroRNA Target Prediction (Supplementary Tables 1 and 2). The
pathway analysis was done using IPA (Ingenuity systems pathway
analysis) to further clarify the molecular functions that miRNAs may
be involved in (Supplementary Table 3). Several immune related
pathways, such as NF-κB signaling and T cell and B cell receptor sig-
naling were included, implying that miRNAs may inﬂuence MD resis-
tance or susceptibility through controlling the immune responses.
The discovery of the miRNA gga-miR-15b target, ATF2, is valuable
for understanding the etiology of MD. ATF2 is a sequence-based
DNA binding protein that belongs to the cAMP-response element
(CRE)-binding protein (CREB) family, which regulates proliferation
and apoptosis by altering downstream gene expression [25]. The
mRNA level of ATF2 was only slightly reduced (20% and 10%, respec-
tively) after MDV infection in line 63 and line 72, suggesting MDV in-
fection did not modulate ATF2 transcription. In line 72 chickens, after
MDV infection, ATF2 protein increased signiﬁcantly compared to non-
infected birds. Interestingly, in the same line, the increase of ATF2
was coincident with the decrease of gga-miR-15b level. Bioinformatics
analysis predicted that ATF2was one of the direct targets for gga-miR-
15b. The luciferase reporter assay showed that gga-miR-15b indeed
depressed ATF2. This information suggested that in line 72, MDV in-
fection resulted in the downregulation of gga-miR-15b thus released
its inhibition on ATF2 translation. The coexpression of ATF2 and gga-
miR-15b was observed in line 63. Traditionally, it is believed that be-
cause of its inhibition effect, miRNA and its target show a mutually
exclusive pattern. However, this classic view has been disputed by re-
cent publications that show miRNA and its target can be coexistent to
maintain the balance of translational network [12,20,27,28]. It
appeared that the abundance of ATF2 protein was similar in line 63
chickens regardless of MDV infection; however, this observation
was not surprising because it was well possible that in this resistant
line, some unknown mechanisms prevent MDV from reducing gga-
miR-15b expression to increase ATF2 translation. The mechanisms
that inhibit MDV-mediated reduction of gga-miR-15b in line 63
remained unclear. The distinct genetic backgrounds, such as SNPs
and gene expression variations between two lines may contribute to
the different regulatory mechanisms. The unique expression pattern
and distinctive regulatory mechanism may suggest that ATF2 plays
different roles in line 72 and line 63. As far as the biological function
of ATF2 is concerned, several lines of evidence suggest that ATF2
may work as an oncogene or tumor suppressor dependent on the
cellular systems. For example, it has been reported that ATF2 elicited
tumor suppressor or oncogene activities in different cancers by coop-
eration with other tumor suppressors or oncogenes [3,4,15]. Chicken
ATF2 was documented to form a heterodimer with c-Jun, MDV onco-
gene Meq and other b-ZIP proteins [15,17,24]. In line 72, we found
the ATF2 protein level was higher in MDV infected birds than unin-
fected chickens. Since MDV oncogene Meq was highly expressed in
line 72 after MDV infection, ATF2 probably formed a heterodimer
with Meq and favor MD development. In the line 63, due to the ab-
sence of Meq after MDV exposure, ATF2 may be in cooperation with
c-Jun and perform distinct functions as in line 72. Considering the dra-
matic difference in Meq expression between infected line 72 and
infected line 63, it is likely that ATF2 may have different partners
and play distinct roles in two chicken lines after MDV infection even
though the expression was similar between infected line 72 and
infected line 63. The other chicken miRNA gga-let-7i, which was also
deregulated in line 72 after MDV challenge, may have negative effects
on ATF2 translation since it slightly suppressed luciferase activities,
but might not control ATF2 translation alone. In general, miRNA regu-
lation of gene expression is largely dependent on binding at the 3′
UTR. However, miRNA target sites in the coding regions of genes
have recently been reported in humans [9]. The validation that gga-
miR-15b reduced ATF2 expression provided further evidence that
the miRNA regulation of gene expression could depend on the bind-
ing at the coding region.In summary, MDV challenge in resistant and susceptible chicken
lines resulted in differential miRNA expression signatures in the
spleens of infected chickens. The expression of most cellular miRNAs
was dramatically decreased, but viral miRNAs were overexpressed in
the MDV-infected susceptible line. In contrast, chicken miRNA tran-
scription was relatively stable while MDV miRNA expression was
suppressed in infected resistant lines. The repression of miRNA re-
sults in distinct target gene expression in the two lines after MDV in-
fection. ATF2was identiﬁed as a direct target for gga-miR-15b, and the
biological consequences of ATF2 on MD resistance and susceptibility
in vivo should be further elucidated.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.ygeno.2011.11.004.
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